The Latest Breaking News from Pfizer

With inflation still alarmingly high, the Fed is poised to raise interest rates further. This is predicted to keep the stock market volatile. Amid this, investors should focus on their long-term strategies and buy fundamentally strong stocks Visa (V), Pfizer (PFE), and Molina Healthcare (MOH), which have solid growth potential.…

Pfizer Inc. is purchasing cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, using the biggest deal of the year to set its course out of the pandemic and back into mainstream pharma.

Here's How a New Covid-19 Vaccine Might Protect Us Against Future Variants

Drug marks ‘significant breakthrough’ for people with migraine who need freedom from pain

The U.S. Food and Drug Administration has approved a nasal spray developed by Pfizer as a means to quickly treat the painful symptoms associated with suffering a migraine.

Around one in 14 of the region's hospital beds are currently occupied by patients with coronavirus

Health and Social Care Secretary Steve Barclay made the announcement on Wednesday

Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.

London is still lagging behind parts of the country in terms of the vaccine uptake